ATC Group: B01AC09 Epoprostenol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B01AC09 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B01 Antithrombotic agents
3 B01A Antithrombotic agents
4 B01AC Platelet aggregation inhibitors excl. heparin
5 B01AC09 Epoprostenol

Active ingredients in B01AC09

Active Ingredient

Epoprostenol sodium, the monosodium salt of epoprostenol, a naturally occurring prostaglandin produced by the intima of blood vessels. Epoprostenol is the most potent inhibitor of platelet aggregation known. It is also a potent vasodilator.

Related product monographs

Document Type Information Source  
 VELETRI Powder for solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

United States medicines

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Canada (CA)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.